Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome.
Sanjiv RisalYu PeiHaojiang LuMaria MantiRomina FornesHan-Pin PuiZhiyi ZhaoJulie MassartClaes OhlssonEva LindgrenNicolas CrisostoManuel MaliqueoBarbara EchiburúAmanda Ladrón de GuevaraTeresa Sir-PetermannHenrik LarssonMina A RosenqvistCarolyn E CestaAnna BenrickQiaolin DengElisabet Stener-VictorinPublished in: Nature medicine (2019)
How obesity and elevated androgen levels in women with polycystic ovary syndrome (PCOS) affect their offspring is unclear. In a Swedish nationwide register-based cohort and a clinical case-control study from Chile, we found that daughters of mothers with PCOS were more likely to be diagnosed with PCOS. Furthermore, female mice (F0) with PCOS-like traits induced by late-gestation injection of dihydrotestosterone, with and without obesity, produced female F1-F3 offspring with PCOS-like reproductive and metabolic phenotypes. Sequencing of single metaphase II oocytes from F1-F3 offspring revealed common and unique altered gene expression across all generations. Notably, four genes were also differentially expressed in serum samples from daughters in the case-control study and unrelated women with PCOS. Our findings provide evidence of transgenerational effects in female offspring of mothers with PCOS and identify possible candidate genes for the prediction of a PCOS phenotype in future generations.